Clicky

Medicover AB(5M0B)

Description: Medicover AB (publ) provides healthcare and diagnostic services in Germany, Sweden, Poland, Turkey, Belarus, Bulgaria, Georgia, Hungary, Serbia, Moldova, Ukraine, and India. It operates through two segment, Healthcare Services and Diagnostic Services. The company's diagnostic services comprise various tests, including allergy and autoimmune diagnostics, bacteriology, parasitology, biochemistry and immunochemistry, blood group diagnostics/transfusion medicine, tumour markers, clinical chemistry, cytology, haematology, histopathology, human genetics, hygiene, immunology and immunochemistry, infectious diseases, microbiology, molecular biology, and pharmacology/toxicology. The company operates 97 clinical laboratories, 733 blood-drawing points, and 26 clinics in 10 countries; and 117 medical clinics, 20 fertility clinics, 52 dental clinics, 25 hospitals, and 25 gyms. It serves corporate and private customers, and patients, as well as public payers. Medicover AB (publ) was founded in 1995 and is headquartered in Stockholm, Sweden.


Keywords: Medicine Infectious Diseases Immunology Clinic Immune System Allergy Pathology Diagnostic Services Transfusion Medicine Tumour

Home Page: www.medicover.com

P.O. Box 5283
Stockholm, 102 46
Sweden
Phone: 46 8 40 01 76 00


Officers

Name Title
Mr. Fredrik Rågmark CEO & Director
Mr. Joe Ryan Chief Financial Officer
Mr. Jaroslaw Urbanczyk Chief Information Officer
Hanna Bjellquist Head of Investor Relations
Ms. Jenny Brandt Gen. Legal Counsel
Dr. Andrew Vallance-Owen Chief Marketing Officer
Ms. Liselotte Bergmark Group Human Resource Director
Mr. John Paul Stubbington Chief Operating Officer of Healthcare Services
Mr. Staffan Ternstrom Chief Operating Officer for Diagnostic Services
Mr. Marcin Radziwill Chief Exec. Officer of Medicover Foundation

Exchange: F

Country: DE

Currency: Euro (€)

Forward PE: 44.6429
Trailing PE: 51.5
Price-to-Book MRQ: 4.4464
Price-to-Sales TTM: 1.3793
IPO Date:
Fiscal Year End: December
Full Time Employees: 38000
Back to stocks